Back to search results
NCT00102544

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Enrolling by Invitation
NAAges 18+InterventionalDevice feasibility
National Institutes of Health Clinical Center (CC)
~3,894 participants
Updated 2026-07-24 on ClinicalTrials.gov
What's tested:EM Tracking

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of using electromagnetic devices in different cohorts.
Measured over Day 1

Conditions

Adenocarcinoma
Prostate Neoplasms
Prostate Cancer
Renal Cell Carcinoma
Von Hippel Lindau Disease

Explore related trials

AdenocarcinomaLiver CarcinomaProstate CarcinomaRenal Cell CarcinomaVon Hippel Lindau Syndrome

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Peter A Pinto, M.D. · PRINCIPAL_INVESTIGATOR · National Institutes of Health Clinical Center (CC)

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Feasibility of using electromagnetic devices in different cohorts.Day 1

    "TRE" Target Registration Error (distance between "virtual" needle position (tracking data) and the actual needle position ("CT" Computed Tomography confirmation scan))